Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4,719

ChatbotGPT is a new artificial intelligence programme designed to simulate human conversation and tackle complex questions.

(Subscribe: https://bit.ly/C4_News_Subscribe)

It’s made by Open AI foundation, a tech-startup co-founded by Elon Musk, and it draws on text taken from a variety of sources on the internet and its creators say it has learned how to answer academic questions, and even sometimes admits when it’s wrong.

We’ve done an interview by putting questions to the chatbot, and then generating a voice for it using different software.

We asked the Chatbot GPT whether fears about A.I. threatening the human race are well-founded.

———————-

Continue reading “New AI chatbot ‘ChatGPT’ interviewed on TV” | >

Environmentalists, however, argue that the process may not be a good thing.

University of Colorado researchers have conceived of a method of making useful materials out of some of the plastics that are inundating landfills everywhere, according to a report by the Colorado Sun.

The end result is a series of polycyanurate networks which have been used for decades in electronic devices, automobiles, circuit boards, the space industry and more.

AzmanJaka/iStock.

The novel process uses ethanol to break down plastics to their smallest molecules. Those molecules are then used as starting blocks to make a new plastic product equally as useful and durable as the recycled one.

Read more | >

It will be jointly built by a Swedish and a Turkish company.

Eco Wave Power (EWP) has signed a deal with Oren Ordu Eneas to build the world’s largest-ever wave power plant on Turkey’s Black Sea coast, according to a press release by the Swedish company published on Thursday.

The project would start with a 4MW pilot in the port of Ordu. It would then move forward to a 77MW plant which would consist of a fixed, modular array of steel floats hinged to piston-equipped arms.

Eco Power Plant.

EWP, which developed and patented, smart and cost-efficient technology for turning ocean and sea waves into green electricity, was founded in Tel Aviv, Israel, in 2011. Oren Ordu Eneas is an affiliate of a local Turkish municipality.

Read more | >

These genetically engineered plants can take over the work of 30 houseplants.

A bioengineered plant is able to clean the air by doing the work of over 30 houseplantsIt could be the start of a bold new industry that develps over the next 15 to 20 years.

The Neo P1 is the first of its kind.

A startup in Paris has developed a plant that could take over the work of 30 houseplants — and it’s just the beginning.

Yuri_Arcurs/iStock.

Neo P1, effectively a super-efficient air purifier, can metabolize four major indoor air pollutants and absorb certain volatile organic compounds, or VOCs. It’s the start of a revolution in plants that could lead to a dramatic new industry.

Continue reading “Plant-based air purifiers are coming to your home — The Blueprint” | >

A close-door “design competition” with selected global construction companies is underway.

Saudi Arabia may be weighing in on plans for a 2-kilometer-tall, world’s tallest tower, for its 18-square-kilometer master-planned area in the capital city of Riyadh.

“Contractors that have priced megatall towers in the region say that depending on the final design, a 2km-tall structure could cost about $5bn to construct,” said the report.

Dblight/iStock.

The proposed skyscraper will be more than twice as tall as Dubai’s Burj Khalifa, which stands at 828 meters and is currently the tallest building in the world, according to a report published by Middle East business intelligence (MEED) magazine on Wednesday.

Read more | >

The oral and skin care brand has already undertaken two other experiments on the space station.

Colgate-Palmolive Company and NASA have entered into a partnership to explore innovative solutions to advance oral health, personal care and skin health for astronauts and even populations on earth, according to a press release by the self-care company published on Wednesday.

The deal will see former astronaut Dr. Cady Coleman join the team as an advisor for the experiments conducted.

Called the Space Act Agreement (SAA), the new project will see Colgate and NASA collaborate to test Colgate technologies, across oral health, skin health, and personal care product categories, that could help maintain or even improve the health and wellbeing of all space travelers in low orbit, either before, during, or after long-duration missions. The agreement will also see the International Space Station (ISS) used as an experimental testing ground.

Read more | >

The study brings much hope to patients with brain and spinal cord cancers.

A small pilot trial involving patients with lymphoma of the brain and/or spinal cord has shown that CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) can be a viable treatment option for patients who often have little hope, according to a press release by Dana-Farber Cancer Institute investigators published on Sunday. “For many patients with lymphoma of the central nervous system, there aren’t great treatment options,” said Dana-Farber’s Caron Jacobson, MD, MMSc, who led the trial.

Our early results suggest that expanding the applicability of CAR-T cells to this indication could improve patient outcomes.

Mohammed Haneefa Nizamudeen/iStock.

Lymphomas typically feature aggressive tumors that can spread to the brain and spinal cord after they originate in other parts of the body. These cancers are often difficult to treat and patients do not survive more than two years.

Read more | >

Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.

The study findings were published in JAMA Oncology and led by Marco Del Chiaro, MD, division chief of surgical oncology in the University of Colorado Department of Surgery and visiting researcher Toshitaka Sugawara, MD, Ph.D.

“It’s critical to have large scale data that doctors can use to make decisions about plans for patients who qualify for surgery,” said author Marco Del Chiaro, MD, division chief of surgical oncology at the CU Cancer Center on the University of Colorado Anschutz Medical Campus.

Read more | >